Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Roberts Jonathan C	2. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [ CVS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP & Chief Operating Officer
(Last) (First) (Middle) ONE CVS DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 11/3/2021
(Street) WOONSOCKET, RI 02895- (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/3/2021		M		108870	A	$45.93	215984.717	D
Common Stock	11/3/2021		S⁽¹⁾		108870	D	$95.00	107114.717	D
Common Stock								34707	I	By GRAT
Common Stock (restricted)								12812	D
ESOP Common Stock								6045	I	By ESOP
Stock Unit								337833.3369	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$45.93	11/3/2021		M			108870	9/4/2015 ⁽²⁾	9/4/2022	Common Stock	108870	$0	0	D
Phantom Stock Credits	$1.00							⁽³⁾	⁽³⁾	Common Stock	1422.6711		1422.6711	D
Stock Option	$102.26							4/1/2016 ⁽⁴⁾	4/1/2022	Common Stock	68482		68482	D
Stock Option	$104.82							4/1/2017 ⁽⁵⁾	4/1/2023	Common Stock	161318		161318	D
Stock Option	$78.05							4/3/2018 ⁽⁶⁾	4/3/2024	Common Stock	200358		200358	D
Stock Option	$62.21							4/1/2019 ⁽⁷⁾	4/1/2025	Common Stock	248131		248131	D
Stock Option	$54.19							4/1/2020 ⁽⁸⁾	4/1/2029	Common Stock	303010		303010	D
Stock Option	$58.34 ⁽⁹⁾							4/1/2021 ⁽¹⁰⁾	4/1/2030	Common Stock	239355		239355	D
Stock Option	$74.30							4/1/2022 ⁽¹¹⁾	4/1/2031	Common Stock	172772		172772	D

Explanation of Responses:
(1)	All sales were effected pursuant to a Rule 10b5-1 plan.
(2)	Option became exercisable in three equal annual installments, commencing 9/4/2015.
(3)	Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
(4)	Option became exercisable in four equal annual installments, commencing 4/1/2016.
(5)	Option became exercisable in four equal annual installments, commencing 4/1/2017.
(6)	Option became exercisable in four equal annual installments, commencing 4/3/2018.
(7)	Option became exercisable in four equal annual installments, commencing 4/1/2019.
(8)	Option became exercisable in four equal annual installments, commencing 4/1/2020.
(9)	The number of shares subject to the option were calculated using a 30-day average price.
(10)	Options became exercisable in four equal installments, commencing 4/1/2021.
(11)	Option becomes exercisable in four equal installments, commencing 4/1/2022.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Roberts Jonathan C ONE CVS DRIVE WOONSOCKET, RI 02895-			EVP & Chief Operating Officer